Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The value of the stock is tied to the eventual cash in their bank account divide

If PTSC commited to issuing dividends on a regular basis on available cash infusion from licensing it would both give a cash return on our investment and the share price would appreciate.

It's been proven that PTSC BOD and management are not equiped to expand by M&A's or by investing in the market.

What better use of the money than returning all profits to the shareholders. If the investment community sees the possibilities of a huge influx of cash from the patents being valid, a positive markmen decision and a generous settlement from current litigation I think we'll all prosper.

GL

Share
New Message
Please login to post a reply